Emerzene
Pre-clinicalWe have harnessed the complexity of nature and genomics to develop the world’s first plant-based non-additive pain medication.
Founded
2018
Focus
Drug Delivery
About
We have harnessed the complexity of nature and genomics to develop the world’s first plant-based non-additive pain medication.
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedMay 15, 2021
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile